• Naomi L. PerryEmail author
  • David A. Camfield


This chapter presents evidence from human clinical trials relating to “adaptogens,” that is, herbal treatments which have been found to be effective in facilitating optimal performance in times of stress, as well as addressing acute symptoms of anxiety. These treatments are most relevant for acute supplementation, although also can be used as chronic treatments.
  • Ashwagandha (Withania somnifera)

  • Roseroot (Rhodiolarosea)

  • Gotu Kola (Centella asiatica)

  • Siberian Ginseng (Eleutherococcus senticosus)

  • Schisandra (Schisandra chinensis)


Elevated Plus Maze Anxiolytic Effect Generalise Anxiety Disorder Acoustic Startle Response Asiatic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Farrell AK, Simpson JA. Effects of relationship functioning on the biological experience of stress and physical health. Curr Opin Psychiatry. 2017;13:49–53.CrossRefGoogle Scholar
  2. 2.
    Burton L, Westen D, Kowalski R. Psychology. 3rd Australian and New Zealand ed. Milton: Wiley Australia; 2012.Google Scholar
  3. 3.
    Provino R. The role of adaptogens in stress management. Australian J Med Herbalism. 2010;22(2):41–9.Google Scholar
  4. 4.
    Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 2009;4(3):198–219.PubMedCrossRefGoogle Scholar
  5. 5.
    Darbinyan V et al. Rhodiolarosea in stress induced fatigue – a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000;7(5):365–71.PubMedCrossRefGoogle Scholar
  6. 6.
    Kulkarni SK, Dhir A. Withaniasomnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1093–105.PubMedCrossRefGoogle Scholar
  7. 7.
    Alramadhan E et al. Dietary and botanical anxiolytics. Med Sci Monit. 2012;18(4):RA40–8.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withaniasomnifera (ashwagandha): a review. Altern Med Rev. 2000;5(4):334–46.PubMedGoogle Scholar
  9. 9.
    Schliebs R et al. Systemic administration of defined extracts from Withaniasomnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and gabaergic markers in rat brain. Neurochem Int. 1997;30(2):181–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Matsuda H et al. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withaniasomnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. 2001;9(6):1499–507.PubMedCrossRefGoogle Scholar
  11. 11.
    Kulkarni S et al. GABA receptor mediated anticonvulsant action of Withaniasomnifera root extract. Indian Drugs. 1993;30(7):305–12.Google Scholar
  12. 12.
    Mehta A et al. Pharmacological effects of Withaniasomnifera root extract on GABAA receptor complex. Indian J Med Res. 1991;94:312–5.PubMedGoogle Scholar
  13. 13.
    Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withaniasomnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav. 2003;75(3):547–55.PubMedCrossRefGoogle Scholar
  14. 14.
    Bhattacharya SK et al. Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withaniasomnifera. Phytother Res. 1987;1(1):32–7.CrossRefGoogle Scholar
  15. 15.
    Archana R, Namasivayam A. Antistressor effect of Withaniasomnifera. J Ethnopharmacol. 1998;64(1):91–3.CrossRefGoogle Scholar
  16. 16.
    Dadkar VN, Ranadive N, Dhar H. Evaluation of antistress (adaptogen) activity of Withaniasomnifera (ashwagandha).Ind J Clin Bio Chem. 1987;2:101–8.Google Scholar
  17. 17.
    Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol. 1994;44(3):131–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Bhattacharya SK et al. Anxiolytic-antidepressant activity of Withaniasomnifera glycowithanolides: an experimental study. Phytomedicine. 2000;7(6):463–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Pratte MA et al. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic Herb Ashwagandha (Withaniasomnifera). J Altern Complement Med. 2014;20(12):901–8.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Andrade C et al. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of Withaniasomnifera. Indian JPsychiatry. 2000;42(3):295.Google Scholar
  21. 21.
    Auddy B, Hazra PJ, Mitra PA. A standardized Withaniasomnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study. J Am Nutraceutical Assoc. 2008;11:50–6.Google Scholar
  22. 22.
    Cooley K et al. Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One. 2009;4(8):e6628.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255–62.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    SudKhyati S, Anup BT. A randomized double blind placebo controlled study of ashwagandha on generalized anxiety disorder. IntAyurvedic Med J. 2013;1:1–7.Google Scholar
  25. 25.
    Jahanbakhsh SP et al. Evaluation of the efficacy of Withaniasomnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: a randomized double-blind placebo-controlled trial. Complement Ther Med. 2016;27:25–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Kushwaha S, Betsy A, Chawla P. Effect of Ashwagandha (Withaniasomnifera) root powder supplementation in treatment of hypertension. Stud Ethno-Med. 2012;6(2):111–5.Google Scholar
  27. 27.
    TalbottSM,KraemerWJ.The cortisol connection: why stress makes you fat and ruins your health-and what you can do about it. Alameda, CA: Hunter House; 2007.Google Scholar
  28. 28.
    Mell C. Dyes, tannins, perfumes, and medicines from Rhodiolarosea. Textile Colorist. 1938;60(715):483–4.Google Scholar
  29. 29.
    Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiolarosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481–93.PubMedCrossRefGoogle Scholar
  30. 30.
    Shevtsov VA et al. A randomized trial of two different doses of a SHR-5 Rhodiolarosea extract versus placebo and control of capacity for mental work. Phytomedicine. 2003;10(2-3):95–105.PubMedCrossRefGoogle Scholar
  31. 31.
    Ming DS et al. Bioactive compounds from Rhodiolarosea (Crassulaceae). Phytother Res. 2005;19(9):740–3.PubMedCrossRefGoogle Scholar
  32. 32.
    Aksyonova R. The stimulating and adaptogenic effect of a purified Rhodiolarosea preparation–rhodosine. In: Stimulants of the central nervous system. Tomsk; 1966. p. 77–9.Google Scholar
  33. 33.
    Saratikov A. Golden root (Rhodiolarosea). Tomsk: Russia; 1974.Google Scholar
  34. 34.
    Sokolov SY et al. Studies of neurotropic activity of new agents isolated from Rodiola-rosea. Khimiko-Farmatsevticheskii Zhurnal. 1985;19(11):1367–71.Google Scholar
  35. 35.
    Petkov VD et al. Effects of alcohol aqueous extract from Rhodiolarosea L. roots on learning and memory. Acta Physiol Pharmacol Bulg. 1986;12(1):3–16.Google Scholar
  36. 36.
    Norr H. Phytochemical and pharmacological Investigations of the Adaptogens: Eleutherococcussenticosus, Ocimum sanctum, Codonopsispilosula, Rhodiolarosea and Rhodiola crenulata. Û Ludwig Maximilians University. Û Muenchen; 1993. p. 228.Google Scholar
  37. 37.
    Wagner H, Nörr H, Winterhoff H. Plant adaptogens. Phytomedicine. 1994;1(1):63–76.PubMedCrossRefGoogle Scholar
  38. 38.
    Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiolarosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105.PubMedCrossRefGoogle Scholar
  39. 39.
    Van Diermen D et al. Monoamine oxidase inhibition by Rhodiolarosea L. roots. J Ethnopharmacol. 2009;122(2):397–401.PubMedCrossRefGoogle Scholar
  40. 40.
    Stancheva S, Mosharrof A. Effect of the extract of Rhodiola-rosea L on the content of the brain biogenic monoamines. Dokladi Na Bolgarskata Akademiya Na Naukite. 1987;40(6):85–7.Google Scholar
  41. 41.
    Kelly GS. Rhodiolarosea: a possible plant adaptogen. Altern Med Rev. 2001;6(3):293–302.PubMedGoogle Scholar
  42. 42.
    Azizov AP, Seifulla RD. The effect of elton, leveton, phytoton, and adapton on the working capacity of experimental animals. Geogr Rev. 1998;88(3):63.Google Scholar
  43. 43.
    Panossian A, Wagner H. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res. 2005;19(10):819–38.PubMedCrossRefGoogle Scholar
  44. 44.
    Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiolarosea (Rhodax®) for generalized anxiety disorder (GAD). J Altern Complement Med. 2008;14(2):175–80.PubMedCrossRefGoogle Scholar
  45. 45.
    Baek JH, Nierenberg AA, Kinrys G. Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Aust N Z J Psychiatry. 2014;48(8):705–15.PubMedCrossRefGoogle Scholar
  46. 46.
    Hellum BH et al. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiolarosea. Planta Med. 2010;76(4):331–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Head KA, Kelly GS. Nutrients and botanicals for treatment of stress: adrenal fatigue, neurotransmitter imbalance, anxiety, and restless sleep. Altern Med Rev. 2009;14(2):114–40.PubMedGoogle Scholar
  48. 48.
    Bradwejn J et al. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centellaasiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol. 2000;20(6):680–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Wijeweera P et al. Evaluation of anxiolytic properties of Gotukola – (Centellaasiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine. 2006;13(9–10):668–76.PubMedCrossRefGoogle Scholar
  50. 50.
    Gohil KJ, Patel JA, Gajjar AK. Pharmacological review on Centellaasiatica: a potential herbal cure-all. Indian J Pharm Sci. 2010;72(5):546–56.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Grimaldi R et al. Pharmacokinetics of the total triterpenic fraction of Centellaasiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid. J Ethnopharmacol. 1990;28(2):235–41.PubMedCrossRefGoogle Scholar
  52. 52.
    Chen Y et al. Effects of total triterpenes of Centellaasiatica on the corticosterone levels in serum and contents of monoamine in depression rat brain. Zhong Yao Cai (Zhongyaocai, Journal of Chinese Medicinal Materials). 2005;28(6):492–6.Google Scholar
  53. 53.
    Chatterjee TK et al. Effects of plant extract Centellaasiatica (Linn.) on cold restraint stress ulcer in rats. Indian J Exp Biol. 1992;30(10):889–91.PubMedGoogle Scholar
  54. 54.
    Awad R et al. Effects of traditionally used anxiolytic botanicals on enzymes of the γ-aminobutyric acid (GABA) system. Can J Physiol Pharmacol. 2007;85(9):933–42.PubMedCrossRefGoogle Scholar
  55. 55.
    Ceremuga TE et al. Evaluation of the anxiolytic and antidepressant effects of asiatic acid, a compound from Gotu kola or Centellaasiatica, in the male Sprague Dawley rat. AANA J. 2015;83(2):91–8.PubMedGoogle Scholar
  56. 56.
    Ramaswamy A, Periyasamy S, Basu N. Pharmacological studies on Centella asaitica Linn.(Brahma manduki)(no Umbelliferae). J Res Indian Med. 1970;4:160–75.Google Scholar
  57. 57.
    Chen SW et al. Anxiolytic-like effect of asiaticoside in mice. Pharmacol Biochem Behav. 2006;85(2):339–44.PubMedCrossRefGoogle Scholar
  58. 58.
    Ernst E. Herbal remedies for anxiety – a systematic review of controlled clinical trials. Phytomedicine. 2006;13(3):205–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Wattanathorn J et al. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centellaasiatica. J Ethnopharmacol. 2008;116(2):325–32.PubMedCrossRefGoogle Scholar
  60. 60.
    Carlson JJ et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc. 2007;107(3):422–32.PubMedCrossRefGoogle Scholar
  61. 61.
    Jana U et al. A clinical study on the management of generalized anxiety disorder with Centellaasiatica. Nepal Med CollJournal (NMCJ). 2010;12(1):8–11.Google Scholar
  62. 62.
    Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centellaasiatica. Rev Esp Enferm Dig. 2005;97(2):115–24.PubMedCrossRefGoogle Scholar
  63. 63.
    Turton S. Centellaasiatica. Australian J Herbal Med. 1993;5(3):57–61.Google Scholar
  64. 64.
    Wielgorskaya T, Takhtadzhi͡an AL. Dictionary of generic names of seed plants. New York: Columbia University Press; 1995.Google Scholar
  65. 65.
    Davydov M, Krikorian AD. Eleutherococcussenticosus (Rupr. and Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol. 2000;72(3):345–93.PubMedCrossRefGoogle Scholar
  66. 66.
    Takeshi D, Sansei N, Yoshihisa N. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin. 2001;22:1057–70.Google Scholar
  67. 67.
    Oates L. Siberian ginseng Eleutherococcussenticosus. J Complement Med. 2008;7(4):44–7 , +67.Google Scholar
  68. 68.
    Pawar VS, Shivakumar H. A current status of adaptogens: natural remedy to stress. Asian Pac J Trop Dis. 2012;2(Suppl1):S480–90.CrossRefGoogle Scholar
  69. 69.
    Mills S, Bone K. Principles and practice of phytotherapy. London: Churchill livigstone; 2000.Google Scholar
  70. 70.
    Panossian A et al. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine. 2009;16(6):617–22.PubMedCrossRefGoogle Scholar
  71. 71.
    FarnsworthNet al. Siberian ginseng (Eleutherococcussenticosus): current status as an adaptogen.In: Wagner H, Hikino H, Farnsworth NR, editors. Economic and medicinal plant research, 1985.Google Scholar
  72. 72.
    Grigorenko G,Berdishev V. The use of tonic drinks and drugs increasing working capacity of sailors during night shifts. In Abstract Book of the Scientific Practical Conference on Medical and Social Aspects of the “Man-Ocean” Problem ,Vladivostok, Russia; 1988.Google Scholar
  73. 73.
    Berdyshev V. Some specific effects of single doses of adaptogens. Valeology: diagnosis, means and practice in health care. IntCollection SciPapers. 1995;2:105–17.Google Scholar
  74. 74.
    Facchinetti F, Neri I, Tarabusi M. Eleutherococcussenticosus reduces cardiovascular stress response in healthy subjects: a randomized, placebo-controlled trial. Stress Health. 2002;18(1):11–7.CrossRefGoogle Scholar
  75. 75.
    Hartz A et al. Randomized controlled trial of Siberian ginseng for chronic fatigue. Psychol Med. 2004;34(01):51–61.PubMedCrossRefGoogle Scholar
  76. 76.
    Schaffler K, Wolf OT, Burkart M. No benefit adding Eleutherococcussenticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study. Pharmacopsychiatry. 2013;46(5):181–90.PubMedCrossRefGoogle Scholar
  77. 77.
    Hung TM et al. Acetylcholinesterase inhibitory effect of lignans isolated fromSchizandra chinensis. Arch Pharm Res. 2007;30(6):685–90.PubMedCrossRefGoogle Scholar
  78. 78.
    Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress—protective activity. Pharmaceuticals. 2010;3(1):188–224.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Szopa A, Ekiert R, Ekiert H. Current knowledge of Schisandra Chinensis. Phytochemsitry reviews. 2016:1–24.Google Scholar
  80. 80.
    Bone K. A clinical guide to blending liquid herbs: herbal formulations for the individual patient. London: Elsevier Health Sciences; 2003.Google Scholar
  81. 81.
    Zhang C et al. Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. Eur J Pharmacol. 2014;744:157–63.PubMedCrossRefGoogle Scholar
  82. 82.
    Chen Y et al. An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill. Int J Biol Macromol. 2012;50(3):844–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Zhao T et al. Antitumor and immunomodulatory activity of a water-soluble low molecular weight polysaccharide from Schisandra chinensis (Turcz.) Baill. Food Chem Toxicol. 2013;55:609–16.PubMedCrossRefGoogle Scholar
  84. 84.
    Lupandin A et al. On the adaptogenic effect of Schizandra and other adaptogens.In Brekhman II, Fruentov NK, editors. Syktyvkar: acute and chronic stress. VL Komarov’s Far East Branch of USSR Academy of Science; 1986. p. 86–90.Google Scholar
  85. 85.
    Lupandin A, Ovsyanikova V. Increasing resistance to unfavourable factors under the effect of Schizandrachinensis extract. In: Brekhman II editor. Physiological mechanisms of adaptation. Russia: Ivanovo State University; 1986. p. 92–7.Google Scholar
  86. 86.
    Lupandin A. The role of catecholaminergic synapses in the mechanisms of the formation of adaptation with the participation of polyphenol adaptogens. Fiziologicheskii zhurnal SSSR imeni IM Sechenova. 1989;75(8):1082–8.Google Scholar
  87. 87.
    Barnaulov OD, Shanin SN. Stress-limiting effect of phytopreparations: endocrine system and detrimental environmental factors. In: Abstracts of the Fourth All-Union Conference, November 1991. Ministry of Health of USSR, Moscow, p. 27.Google Scholar
  88. 88.
    Panossian A, Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 2008;118(2):183–212.PubMedCrossRefGoogle Scholar
  89. 89.
    Chen W-W et al. Pharmacological studies on the anxiolytic effect of standardized Schisandra lignans extract on restraint-stressed mice. Phytomedicine. 2011;18(13):1144–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Kim SR et al. Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity. J Neurosci Res. 2004;76(3):397–405.PubMedCrossRefGoogle Scholar
  91. 91.
    You JS, Pan TL, Hou YC. Schisandra chinensis protects against adriamycin-induced cardiotoxicity in rats. Chang Gung Med J. 2006;29(1):63–70.PubMedGoogle Scholar
  92. 92.
    Xia N et al. Schisandra chinensis and Rhodiolarosea exert an anti-stress effect on the HPA axis and reduce hypothalamic c-Fos expression in rats subjected to repeated stress. Exp Ther Med. 2016;11(1):353–9.PubMedGoogle Scholar
  93. 93.
    Wu YY et al. Effects of the aqueous extract of Schizandra chinensis fruit on ethanol withdrawal-induced anxiety in rats. Chin Med J (Engl). 2014;127(10):1935–40.Google Scholar
  94. 94.
    Lebedev A. Comparative evaluation of the stimulating effect of various Schizandra products. In Materials for the study of stimulants and tonics from Ginseng and Schizandra roots. Issue 1. Vladivostok: Komarovs’ Far East Branch of USSR Academy of Science. 1951. p. 103–8.Google Scholar
  95. 95.
    Lebedev A. Some materials on the pharmacology of schizandrin. Issue 1. Vladivostok: Komarovs’ Far East Branch of USSR Academy of Science. 1951. p. 109–17.Google Scholar
  96. 96.
    Lebedev A. Schizandrin—a new stimulant from Schizandrachinensis fruits. Summary of Thesis for a Candidate’s Degree in Medicine, Tashkent; 1967.Google Scholar
  97. 97.
    Kochmareva L. The effect of Schizandrachinensis and Ginseng on processes of concentration. In: Lazarev (ed.). Materials for the study of Ginseng and Leningrad: V. L. Komarov’s Far East Branch of USSR Academy of Science. 1958. p. 12–17.Google Scholar
  98. 98.
    Gubchenko P, Fruentov N. A comparative study of stimulating effect of adaptogenic agents prepared from some far-eastern plants. New data on Eleutherococcus and other adaptogens. Vladivostok: USSR Academy of Science, Far East Science Center, Institute of Marin Biology; 1981. p. 18–25.Google Scholar
  99. 99.
    Gubchenko P, Fruentov N. Comparative study of the effectiveness of Eleutherococcus and other plant adaptogens as remedies for increasing the work capacity of flight personnel. In Newdata on Eleutherococcus: proceedings of the 2nd international symposium on Eleutherococcus (Moscow, 1984). Vladivostok: Far East Academy of Science of the USSR; 1986.Google Scholar
  100. 100.
    Panossian AG et al. Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva. Phytomedicine. 1999;6(1):17–26.PubMedCrossRefGoogle Scholar
  101. 101.
    Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 2006;20(5):424–5.PubMedCrossRefGoogle Scholar
  102. 102.
    Bogatova RI et al. Evaluation of the effect of a single dose of phytoadaptogen on human's working ability during long-term isolation. Aviakosmicheskaia i ekologicheskaia meditsina(Aerospace and Environmental Medicine). 1997;31(4):51–4.Google Scholar
  103. 103.
    Bogatova R, Malozemov V. Experimental research on estimation of influence of single dose of phytoadaptogens on short memory. The report on Moscow: Institute of Medical and Biological Problems (IMBP). 1994. p. 1–151.Google Scholar
  104. 104.
    Aslanyan G et al. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine. 2010;17(7):494–9.PubMedCrossRefGoogle Scholar
  105. 105.
    Narimanian M et al. Impact of Chisan® (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia. Phytomedicine. 2005;12(10):723–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Roslyakova N et al. The effect of single dose of Rodelim phytoadaptogen on the performance of operators under intensive activity. In Abstract book of scientific conference biologically active food supplements and natural medicines in prophylaxis, treatment and rehabilitation, Moscow, Russia; 2000.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Centre for Human Psychopharmacology, Swinburne University of TechnologyHawthornAustralia
  2. 2.Centre for Human Psychopharmacology, Swinburne University of TechnologyHawthornAustralia
  3. 3.School of Psychology, University of WollongongWollongongAustralia

Personalised recommendations